These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8595140)

  • 1. Aspects of one-carbon folate cycling related to fluoropyrimidine and antifolate therapy.
    Spears CP; Carlsson G; Muggia FM; Jaresko G; Gustavsson BG
    Cancer Treat Res; 1995; 78():115-34. PubMed ID: 8595140
    [No Abstract]   [Full Text] [Related]  

  • 2. Folate depletion increases sensitivity of solid tumor cell lines to 5-fluorouracil and antifolates.
    Backus HH; Pinedo HM; Wouters D; Padrón JM; Molders N; van Der Wilt CL; van Groeningen CJ; Jansen G; Peters GJ
    Int J Cancer; 2000 Sep; 87(6):771-8. PubMed ID: 10956384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of folate metabolism: features relevant to the action and toxicities of antifolate anticancer agents.
    Calvert H
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):3-10. PubMed ID: 10598549
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular basis of antifolate resistance.
    Assaraf YG
    Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
    van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
    Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Enigma of fluorouracil and levamisole.
    Healy JB
    J Natl Cancer Inst; 1995 Oct; 87(19):1486. PubMed ID: 7674336
    [No Abstract]   [Full Text] [Related]  

  • 8. The folate receptor as a potential therapeutic anticancer target.
    Gruner BA; Weitman SD
    Invest New Drugs; 1998-1999; 16(3):205-19. PubMed ID: 10360600
    [No Abstract]   [Full Text] [Related]  

  • 9. Folate, antifolates, and folate analogs in pediatric oncology.
    Hum MC; Kamen BA
    Invest New Drugs; 1996; 14(1):101-11. PubMed ID: 8880397
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative effects of folate antagonists versus enzymatic folate depletion on folate and thymidine enzymes in cultured mammalian cells.
    Chello PL; McQueen CA; DeAngelis LM; Bertino JR
    Cancer Treat Rep; 1977 Jul; 61(4):539-48. PubMed ID: 195727
    [No Abstract]   [Full Text] [Related]  

  • 11. Folylpoly-γ-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer.
    Raz S; Stark M; Assaraf YG
    Drug Resist Updat; 2016 Sep; 28():43-64. PubMed ID: 27620954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
    Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
    Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogs.
    Goldman ID; Chattopadhyay S; Zhao R; Moran R
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1409-23. PubMed ID: 21154123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on antifolate drugs targets.
    Costi MP; Ferrari S
    Curr Drug Targets; 2001 Jun; 2(2):135-66. PubMed ID: 11469716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate and antifolate pharmacology.
    Kamen B
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-30-S18-39. PubMed ID: 9420019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidylate synthase: a critical target for cancer chemotherapy.
    Rose MG; Farrell MP; Schmitz JC
    Clin Colorectal Cancer; 2002 Feb; 1(4):220-9. PubMed ID: 12450420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular aspects of folate and antifolate membrane transport.
    Brzezińska A; Wińska P; Balińska M
    Acta Biochim Pol; 2000; 47(3):735-49. PubMed ID: 11310973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimetabolites.
    Allegra CJ; Baram J; Chabner BA; Yeh GC; Aiba K; Curt GA
    Cancer Chemother Biol Response Modif; 1987; 9():1-22. PubMed ID: 2484324
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitochondrial translation requires folate-dependent tRNA methylation.
    Morscher RJ; Ducker GS; Li SH; Mayer JA; Gitai Z; Sperl W; Rabinowitz JD
    Nature; 2018 Feb; 554(7690):128-132. PubMed ID: 29364879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and in vitro testing of antifolate inhibitors of human cytosolic serine hydroxymethyltransferase.
    Paiardini A; Fiascarelli A; Rinaldo S; Daidone F; Giardina G; Koes DR; Parroni A; Montini G; Marani M; Paone A; McDermott LA; Contestabile R; Cutruzzolà F
    ChemMedChem; 2015 Mar; 10(3):490-7. PubMed ID: 25677305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.